8-K: DarioHealth Corp. Announces CFO Transition: Zvi Ben-David Resigns, Chen Franco-Yehuda Appointed
8-K Filing
DarioHealth Corp. announces the resignation of CFO Zvi Ben-David, effective May 15, 2025, and the appointment of Chen Franco-Yehuda as the new CFO, also effective May 15, 2025.
Summary
- DarioHealth Corp. announced that Zvi Ben-David resigned as Chief Financial Officer, Treasurer, and Secretary, effective May 15, 2025.
- The resignation was for personal reasons and not due to any disagreement with the company.
- Chen Franco-Yehuda, age 41, has been appointed as the new Chief Financial Officer, Treasurer, and Secretary, effective May 15, 2025.
- Prior to this appointment, Mrs. Franco-Yehuda served as Chief Financial Officer, Treasurer, and Secretary of Pluri Inc. from March 2019 to October 2024.
- She also held positions at PricewaterhouseCoopers (PwC) and the Open University of Israel.
- Mrs. Franco-Yehuda is a board member at Brenmiller Energy Ltd. and serves on its audit and compensation committee.
- Her monthly salary will be NIS 82,000 (approximately $22,245), with a target bonus of up to six times her base salary.
- She will receive 500,000 restricted shares of the company's common stock, vesting over three years.
- Zvi Ben-David will remain with the company as a member of its advisory board.
- Mr. Ben-David will receive a reduced monthly payment of NIS 52,500 (approximately $14,266) from July 1, 2025, through December 31, 2025, and NIS 47,775 (approximately $12,982) from January 1, 2026, through October 31, 2027.
Sentiment
Score: 7
Explanation: The announcement is neutral to positive. The transition appears well-managed, and the incoming CFO has a strong background. The outgoing CFO's continued involvement as an advisor provides stability.
Positives
- The transition appears amicable, with the outgoing CFO remaining as an advisor.
- The incoming CFO has a strong background in finance and accounting, including experience at Pluri Inc. and PricewaterhouseCoopers.
- The compensation package for the new CFO includes a significant potential bonus and equity, aligning her interests with the company's performance.
Negatives
- The resignation of a CFO can create uncertainty, although the company is managing the transition smoothly.
- The company will be paying both the new CFO and the former CFO for a period of time, increasing expenses.
Risks
- The new CFO's performance and ability to integrate into the company's culture are uncertain.
- The company's ability to achieve the milestones required for the new CFO's target bonus is not guaranteed.
- Changes in leadership can sometimes disrupt company strategy and operations.
Future Outlook
The company is focused on ensuring a smooth transition with the new CFO and continuing its operations.
Management Comments
- Zvi has asked to retire from his position after more than 10 years of service and would like to have more time with his family and explore new directions, and therefore will move to a part time position as advisory board member.
Industry Context
CFO transitions are common in the corporate world, and this announcement reflects a planned change in leadership at DarioHealth Corp.
Comparison to Industry Standards
- Compensation packages for CFOs in similar Nasdaq-listed companies typically include a base salary, bonus potential, and equity grants.
- The vesting schedule for the restricted shares is fairly standard, with one-third vesting after one year and the remainder vesting quarterly.
- The severance arrangement for the outgoing CFO is also typical, providing a transition period and continued compensation.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | Zvi Ben-David | Chen Franco-Yehuda | May 15, 2025 | Zvi Ben-David's resignation for personal reasons. |
| Treasurer | Zvi Ben-David | Chen Franco-Yehuda | May 15, 2025 | Zvi Ben-David's resignation for personal reasons. |
| Secretary | Zvi Ben-David | Chen Franco-Yehuda | May 15, 2025 | Zvi Ben-David's resignation for personal reasons. |
Stakeholder Impact
- Shareholders may react to the CFO transition, but the smooth transition and qualified successor should mitigate any negative impact.
- Employees may experience some disruption during the transition period.
- The transition is unlikely to have a significant impact on customers, suppliers, or creditors.
Next Steps
- Chen Franco-Yehuda will assume her role as CFO, Treasurer, and Secretary on May 15, 2025.
- Zvi Ben-David will transition to his role as an advisory board member.
- The company will file a report to the SEC and/or the NASDAQ, as required by law.
Key Dates
| Date | Description |
|---|---|
| January 8, 2015 | Zvi Ben David's Commencement Date |
| April 17, 2025 | Date of Chen Franco Yehuda's Personal Employment Agreement |
| April 18, 2025 | Date of Zvi Ben-David's resignation and Chen Franco-Yehuda's appointment. |
| April 21, 2025 | Date of the 8-K filing. |
| April 27, 2025 | Chen Franco-Yehuda's Commencement Date. |
| May 15, 2025 | Effective date of Zvi Ben-David's resignation and Chen Franco-Yehuda's appointment. |
| July 1, 2025 | Start date of Zvi Ben-David's reduced monthly payments. |
| December 31, 2025 | End date of Zvi Ben-David's higher reduced monthly payments. |
| January 1, 2026 | Start date of Zvi Ben-David's lower reduced monthly payments. |
| October 31, 2027 | End date of Zvi Ben-David's reduced monthly payments and termination date. |
Keywords
CFO, DarioHealth, Appointment, Resignation, Franco-Yehuda, Ben-David, Financial Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.